Concordance Between the Measurement of Whole Blood Fibrinogen by the qLabs®FIB Analyzer and Its Measurement by Conventional Method (Clauss Fibrinogen) in the Context of Severe Postpartum Haemorrhage

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Postpartum Hemorrhage
Interventions
BIOLOGICAL

Fibrinogen concentration by the qLabs®FIB Monitoring system

A drop of blood (\~15 μL) is taken from the blood sample for the complete haemostasis assessment (prothrombin level, activated partial thromboplastin time, fibrinogen). This assessment is part of the usual management of severe postpartum haemorrhage. It is carried out urgently in the hospital's medical biology laboratory at the start of treatment (T1) and during or at the end of treatment of the haemorrhage (T2). This drop of blood will allow the measurement of the fibrinogen concentration by the qLabs®FIB Monitoring system for the study at these two times.

Trial Locations (2)

75014

RECRUITING

Hôpital Cochin Maternité Port Royal, Paris

75015

RECRUITING

Hôpital Necker-Enfants Malades, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER